Advocate Lutheran General Hospital - Medicare Acute Care Hospital in Park Ridge, IL

Advocate Lutheran General Hospital is a medicare enrolled Acute Care Hospital in Park Ridge, Illinois. It is located at 1775 Dempster St, Park Ridge, Illinois 60068. You can reach out to the office of Advocate Lutheran General Hospital via phone at (847) 723-2210.

The ownership type of Advocate Lutheran General Hospital is Voluntary non-profit - Church and it provides emergency services (Emergency Room). The Medicare ID (also called CCN - CMS Certification Number) for Advocate Lutheran General Hospital is 140223.

Contact Information

Advocate Lutheran General Hospital
1775 Dempster St, Park Ridge, Illinois 60068
(847) 723-2210

Hospital Profile

NameAdvocate Lutheran General Hospital
TypeAcute Care Hospital
Location1775 Dempster St, Park Ridge, Illinois
OwnershipVoluntary non-profit - Church
Emergency ServicesYes
Medicare ID (CCN)140223

Patients' Experience Survey:


Overall Rating of the Hospital:

Willingness to Recommend Hospital:
79%
17%
4%
Yes Patients who reported YES, they would definitely recommend the hospital
Probably Patients who reported YES, they would probably recommend the hospital
No Patients who reported NO, they would probably not or definitely not recommend the hospital

Cleanliness of Hospital Environment:
69%
22%
9%
Always Patients who reported that their room and bathroom were "Always" clean
Usually Patients who reported that their room and bathroom were "Usually" clean
Sometimes or Never Patients who reported that their room and bathroom were "Sometimes" or "Never" clean

Quietness of Hospital Environment:
54%
33%
13%
Always Patients who reported that the area around their room was "Always" quiet at night
Usually Patients who reported that the area around their room was "Usually" quiet at night
Sometimes or Never Patients who reported that the area around their room was "Sometimes" or "Never" quiet at night

Nurse Communication:
80%
16%
4%
Always Patients who reported that their nurses "Always" communicated well
Usually Patients who reported that their nurses "Usually" communicated well
Sometimes or Never Patients who reported that their nurses "Sometimes" or "Never" communicated well

Doctor Communication:
81%
15%
4%
Always Patients who reported that their doctors "Always" communicated well
Usually Patients who reported that their doctors "Usually" communicated well
Sometimes or Never Patients who reported that their doctors "Sometimes" or "Never" communicated well

Responsiveness of Hospital Staff:
64%
25%
11%
Always Patients who reported that they "Always" received help as soon as they wanted
Usually Patients who reported that they "Usually" received help as soon as they wanted
Sometimes or Never Patients who reported that they "Sometimes" or "Never" received help as soon as they wanted

Communication about Medicines:
65%
16%
19%
Always Patients who reported that staff "Always" explained about medicines before giving it to them
Usually Patients who reported that staff "Usually" explained about medicines before giving it to them
Sometimes or Never Patients who reported that staff "Sometimes" or "Never" explained about medicines before giving it to them

Discharge Information:
89%
11%
Yes Patients who reported that YES, they were given information about what to do during their recovery at home
No Patients who reported that NO, they were not given information about what to do during their recovery at home

Care Transition:
55%
40%
5%
Always Patients who "Strongly Agree" they understood their care when they left the hospital
Usually Patients who “Agree” they understood their care when they left the hospital
Sometimes or Never Patients who “Disagree” or “Strongly Disagree” they understood their care when they left the hospital

NPI Associated with the Hospital:

Unlike individual providers, Hospitals may have multiple NPI numbers for example, there can be a separate NPI for each unit within the hospital. We have found possible NPI number/s associated with Advocate Lutheran General Hospital from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1023308608
Organization NameADVOCATE LUTHERAN GENERAL HOSPITAL
Address1775 W Dempster St, 8 South, Park Ridge, IL 60068
Hospital TypeGeneral Acute Care Hospital - Children
Phone Number847-723-8077

News Archive

Insurance commissioners back brokers on health law standard

After more than a year of debate, state regulators ... approved a resolution calling for changes to the healthcare reform law's medical loss ratio provision. The National Association of Insurance Commissioners (NAIC) passed the measure 26-20, over strenuous objections from commissioners who said the process and the resolution itself would undermine the NAIC's reputation.

Oncolytics' REOLYSIN granted EMA Orphan Drug Designation for treatment of gynecological cancers

Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the European Medicines Agency has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of ovarian, fallopian tube and primary peritoneal cancers.

Restaurant owner welcomes delay on law's insurance requirement

The New York Times profiles the challenges that one business owner faced with the health law. Other outlets offer news on the law, including the problems the administration faces in setting up the online marketplaces, concerns about scams targeting consumers and help for Medicare beneficiaries.

Ipsen's phase III clinical trial evaluating Decapeptyl in patients with prostate cancer meets primary endpoints

Ipsen today announced that the phase III clinical trial evaluating Decapeptyl (triptorelin pamoate) 11.25 mg administered subcutaneously in patients with locally advanced or metastatic prostate cancer has met its primary endpoints.

Read more Medical News

› Verified 5 days ago


NPI Number1376709527
Organization NameIRMA ESPOSITO
Address1775 Dempster St, Park Ridge, IL 60068
Hospital TypeGeneral Acute Care Hospital
Phone Number123-456-7890

News Archive

Insurance commissioners back brokers on health law standard

After more than a year of debate, state regulators ... approved a resolution calling for changes to the healthcare reform law's medical loss ratio provision. The National Association of Insurance Commissioners (NAIC) passed the measure 26-20, over strenuous objections from commissioners who said the process and the resolution itself would undermine the NAIC's reputation.

Oncolytics' REOLYSIN granted EMA Orphan Drug Designation for treatment of gynecological cancers

Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the European Medicines Agency has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of ovarian, fallopian tube and primary peritoneal cancers.

Restaurant owner welcomes delay on law's insurance requirement

The New York Times profiles the challenges that one business owner faced with the health law. Other outlets offer news on the law, including the problems the administration faces in setting up the online marketplaces, concerns about scams targeting consumers and help for Medicare beneficiaries.

Ipsen's phase III clinical trial evaluating Decapeptyl in patients with prostate cancer meets primary endpoints

Ipsen today announced that the phase III clinical trial evaluating Decapeptyl (triptorelin pamoate) 11.25 mg administered subcutaneously in patients with locally advanced or metastatic prostate cancer has met its primary endpoints.

Read more Medical News

› Verified 5 days ago


NPI Number1386779031
Organization NameADVOCATE LUTHERAN GENERAL
Address1775 Dempster St, Park Ridge, IL 60068
Hospital TypeGeneral Acute Care Hospital
Phone Number847-723-7315

News Archive

Insurance commissioners back brokers on health law standard

After more than a year of debate, state regulators ... approved a resolution calling for changes to the healthcare reform law's medical loss ratio provision. The National Association of Insurance Commissioners (NAIC) passed the measure 26-20, over strenuous objections from commissioners who said the process and the resolution itself would undermine the NAIC's reputation.

Oncolytics' REOLYSIN granted EMA Orphan Drug Designation for treatment of gynecological cancers

Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the European Medicines Agency has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of ovarian, fallopian tube and primary peritoneal cancers.

Restaurant owner welcomes delay on law's insurance requirement

The New York Times profiles the challenges that one business owner faced with the health law. Other outlets offer news on the law, including the problems the administration faces in setting up the online marketplaces, concerns about scams targeting consumers and help for Medicare beneficiaries.

Ipsen's phase III clinical trial evaluating Decapeptyl in patients with prostate cancer meets primary endpoints

Ipsen today announced that the phase III clinical trial evaluating Decapeptyl (triptorelin pamoate) 11.25 mg administered subcutaneously in patients with locally advanced or metastatic prostate cancer has met its primary endpoints.

Read more Medical News

› Verified 5 days ago


NPI Number1528388634
Organization NameADVOCATE LUTHERAN GENERAL HOSPITAL
Address1775 W Dempster St, 8 South, Park Ridge, IL 60068
Hospital TypeGeneral Acute Care Hospital
Phone Number847-723-5871

News Archive

Insurance commissioners back brokers on health law standard

After more than a year of debate, state regulators ... approved a resolution calling for changes to the healthcare reform law's medical loss ratio provision. The National Association of Insurance Commissioners (NAIC) passed the measure 26-20, over strenuous objections from commissioners who said the process and the resolution itself would undermine the NAIC's reputation.

Oncolytics' REOLYSIN granted EMA Orphan Drug Designation for treatment of gynecological cancers

Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the European Medicines Agency has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of ovarian, fallopian tube and primary peritoneal cancers.

Restaurant owner welcomes delay on law's insurance requirement

The New York Times profiles the challenges that one business owner faced with the health law. Other outlets offer news on the law, including the problems the administration faces in setting up the online marketplaces, concerns about scams targeting consumers and help for Medicare beneficiaries.

Ipsen's phase III clinical trial evaluating Decapeptyl in patients with prostate cancer meets primary endpoints

Ipsen today announced that the phase III clinical trial evaluating Decapeptyl (triptorelin pamoate) 11.25 mg administered subcutaneously in patients with locally advanced or metastatic prostate cancer has met its primary endpoints.

Read more Medical News

› Verified 5 days ago


NPI Number1619002284
Organization NameADVOCATE LUTHERAN GENERAL HOSPITAL
Address1775 Dempster St, Park Ridge, IL 60068
Hospital TypeGeneral Acute Care Hospital
Phone Number847-723-7313

News Archive

Insurance commissioners back brokers on health law standard

After more than a year of debate, state regulators ... approved a resolution calling for changes to the healthcare reform law's medical loss ratio provision. The National Association of Insurance Commissioners (NAIC) passed the measure 26-20, over strenuous objections from commissioners who said the process and the resolution itself would undermine the NAIC's reputation.

Oncolytics' REOLYSIN granted EMA Orphan Drug Designation for treatment of gynecological cancers

Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the European Medicines Agency has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of ovarian, fallopian tube and primary peritoneal cancers.

Restaurant owner welcomes delay on law's insurance requirement

The New York Times profiles the challenges that one business owner faced with the health law. Other outlets offer news on the law, including the problems the administration faces in setting up the online marketplaces, concerns about scams targeting consumers and help for Medicare beneficiaries.

Ipsen's phase III clinical trial evaluating Decapeptyl in patients with prostate cancer meets primary endpoints

Ipsen today announced that the phase III clinical trial evaluating Decapeptyl (triptorelin pamoate) 11.25 mg administered subcutaneously in patients with locally advanced or metastatic prostate cancer has met its primary endpoints.

Read more Medical News

› Verified 5 days ago


NPI Number1619237203
Organization NameADVOCATE HEALTH CARE
Address1775 W Dempster St, Park Ridge, IL 60068
Hospital TypeGeneral Acute Care Hospital
Phone Number847-723-2210

News Archive

Insurance commissioners back brokers on health law standard

After more than a year of debate, state regulators ... approved a resolution calling for changes to the healthcare reform law's medical loss ratio provision. The National Association of Insurance Commissioners (NAIC) passed the measure 26-20, over strenuous objections from commissioners who said the process and the resolution itself would undermine the NAIC's reputation.

Oncolytics' REOLYSIN granted EMA Orphan Drug Designation for treatment of gynecological cancers

Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the European Medicines Agency has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of ovarian, fallopian tube and primary peritoneal cancers.

Restaurant owner welcomes delay on law's insurance requirement

The New York Times profiles the challenges that one business owner faced with the health law. Other outlets offer news on the law, including the problems the administration faces in setting up the online marketplaces, concerns about scams targeting consumers and help for Medicare beneficiaries.

Ipsen's phase III clinical trial evaluating Decapeptyl in patients with prostate cancer meets primary endpoints

Ipsen today announced that the phase III clinical trial evaluating Decapeptyl (triptorelin pamoate) 11.25 mg administered subcutaneously in patients with locally advanced or metastatic prostate cancer has met its primary endpoints.

Read more Medical News

› Verified 5 days ago


NPI Number1699927186
Organization NameADVOCATE LUTHERAN GENERAL HOSPITAL
Address1775 Dempster St, Park Ridge, IL 60068
Hospital TypeGeneral Acute Care Hospital
Phone Number847-723-7748

News Archive

Insurance commissioners back brokers on health law standard

After more than a year of debate, state regulators ... approved a resolution calling for changes to the healthcare reform law's medical loss ratio provision. The National Association of Insurance Commissioners (NAIC) passed the measure 26-20, over strenuous objections from commissioners who said the process and the resolution itself would undermine the NAIC's reputation.

Oncolytics' REOLYSIN granted EMA Orphan Drug Designation for treatment of gynecological cancers

Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the European Medicines Agency has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of ovarian, fallopian tube and primary peritoneal cancers.

Restaurant owner welcomes delay on law's insurance requirement

The New York Times profiles the challenges that one business owner faced with the health law. Other outlets offer news on the law, including the problems the administration faces in setting up the online marketplaces, concerns about scams targeting consumers and help for Medicare beneficiaries.

Ipsen's phase III clinical trial evaluating Decapeptyl in patients with prostate cancer meets primary endpoints

Ipsen today announced that the phase III clinical trial evaluating Decapeptyl (triptorelin pamoate) 11.25 mg administered subcutaneously in patients with locally advanced or metastatic prostate cancer has met its primary endpoints.

Read more Medical News

› Verified 5 days ago


NPI Number1891830352
Organization NameLUTHERAN GENERAL HOSPITAL
Address1775 W Dempster St, Park Ridge, IL 60068
Hospital TypePsychiatric Hospital
Phone Number847-723-2210

News Archive

Insurance commissioners back brokers on health law standard

After more than a year of debate, state regulators ... approved a resolution calling for changes to the healthcare reform law's medical loss ratio provision. The National Association of Insurance Commissioners (NAIC) passed the measure 26-20, over strenuous objections from commissioners who said the process and the resolution itself would undermine the NAIC's reputation.

Oncolytics' REOLYSIN granted EMA Orphan Drug Designation for treatment of gynecological cancers

Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the European Medicines Agency has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of ovarian, fallopian tube and primary peritoneal cancers.

Restaurant owner welcomes delay on law's insurance requirement

The New York Times profiles the challenges that one business owner faced with the health law. Other outlets offer news on the law, including the problems the administration faces in setting up the online marketplaces, concerns about scams targeting consumers and help for Medicare beneficiaries.

Ipsen's phase III clinical trial evaluating Decapeptyl in patients with prostate cancer meets primary endpoints

Ipsen today announced that the phase III clinical trial evaluating Decapeptyl (triptorelin pamoate) 11.25 mg administered subcutaneously in patients with locally advanced or metastatic prostate cancer has met its primary endpoints.

Read more Medical News

› Verified 5 days ago


Structural Quality Measures:

Able to receive lab results electronicallyYes
Able to track patients' lab results, tests, and referrals electronically between visitsYes

News Archive

Insurance commissioners back brokers on health law standard

After more than a year of debate, state regulators ... approved a resolution calling for changes to the healthcare reform law's medical loss ratio provision. The National Association of Insurance Commissioners (NAIC) passed the measure 26-20, over strenuous objections from commissioners who said the process and the resolution itself would undermine the NAIC's reputation.

Oncolytics' REOLYSIN granted EMA Orphan Drug Designation for treatment of gynecological cancers

Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the European Medicines Agency has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of ovarian, fallopian tube and primary peritoneal cancers.

Restaurant owner welcomes delay on law's insurance requirement

The New York Times profiles the challenges that one business owner faced with the health law. Other outlets offer news on the law, including the problems the administration faces in setting up the online marketplaces, concerns about scams targeting consumers and help for Medicare beneficiaries.

Ipsen's phase III clinical trial evaluating Decapeptyl in patients with prostate cancer meets primary endpoints

Ipsen today announced that the phase III clinical trial evaluating Decapeptyl (triptorelin pamoate) 11.25 mg administered subcutaneously in patients with locally advanced or metastatic prostate cancer has met its primary endpoints.

Read more News

› Verified 5 days ago

Hospitals in Park Ridge, IL

Advocate Lutheran General Hospital
Acute Care Hospital
Location: 1775 Dempster St, Park Ridge, Illinois 60068
Phone: (847) 723-2210    

Medicare Hospital Compare

Hospital Compare provide information about the quality of care at over 4,000 Medicare-certified hospitals across the country. You can use Hospital Compare to find hospitals and compare the quality of their care. The information on Hospital Compare:
  • Helps you make decisions about where you get your health care
  • Encourages hospitals to improve the quality of care they provide
In an emergency, you should go to the nearest hospital. When you can plan ahead, discuss the information you find here with your health care provider to decide which hospital will best meet your health care needs. Hospital Compare was created through the efforts of the Centers for Medicare & Medicaid Services (CMS), in collaboration with organizations representing consumers, hospitals, doctors, employers, accrediting organizations, and other federal agencies.

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.